This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: NFLX, AA, MU, KMX


Hanesbrands (HBI) was initiated with a neutral rating at Goldman Sachs. $23 price target. Attractive business but facing several challenges.

Juniper Networks (JNPR - Get Report) was upgraded from market perform to outperform at BMO Capital Markets. $25 price target. Valuation call.

ViroPharma (VPHM) was initiated with a buy rating at Brean Murray. $37 price target. Stregnth of orphan drug, Cinryze.

Wabco (WBC) WBC was upgraded to overweight at JPMorgan. Unique buying opportunity.


Alcoa (AA - Get Report) estimates lowered through 2011, Morgan Stanley said. Should retain defensive appeal despite headwinds. Overweight rating and $13 price target.

Actuant (ATU) numbers raised at Jefferies. Shares of ATU now seen reaching $31, Jefferies said. High-quality first quarter and beat. Buy rating.

Bed Bath & Beyond (BBBY) estimates increased through 2013, UBS said. Solid results and margin expansion. Maintain $64 price target and neutral rating.

CVS Caremark (CVS - Get Report) target raised at Goldman Sachs. Shares of CVS now seen reaching $44, Goldman Sachs said. Revived credibility yields confidence in growth algorithm. Buy rating.

Emerson Electric (EMR - Get Report) numbers lowered at UBS. Shares of EMR now seen reaching $50, according to UBS. Estimates also lowered on climate weakness and flat year-over-year orders. Neutral rating.

Emerson Electric numbers cut at Citigroup. Shares of EMR now seen reaching $56, according to Citigroup. Estimates also lowered on Thai flood, destocking, and pockets of lower demand. Buy rating.

Emerson Electric target lowered at Goldman Sachs. Shares of EMR now seen reaching $51, Goldman Sachs said. Facing incremental demand weakness. Buy rating.

CarMax (KMX - Get Report) numbers lowered Goldman Sachs. Shares of KMX now seen reaching $29, Goldman Sachs said. Estimates also lowered on softer same-store unit trends. Neutral rating.

CarMax estimates, target cut at Deutsche Bank. Shares of KMX now seen reaching $31, according to Deutsche Bank. Estimates also lowered as company missed volume and profit expectations.

Micron Technology (MU - Get Report) numbers cut at UBS. Shares of MU now seen reaching $12, according to UBS. Estimates also lowered on DRAM margin erosion. Buy rating.

Micron technology estimates lowered through 2013, Sterne Agee said. Guided NANA-DRAM outlook down. $11 price target and buy rating.

Netflix (NFLX - Get Report) estimates, target lowered at Citigroup. Shares of NFLX now seen reaching $80, according to Citigroup. Estimates also lowered on segment rebuild and disclosure about 2012 losses. Neutral rating.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AA $11.17 0.18%
CVS $100.50 -0.70%
EMR $54.63 -0.71%
JNPR $23.40 -0.04%
KMX $52.95 -1.82%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs